Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen, G-CSF and Plerixafor Mobilization in X-CGD
NCT03055247Phase 2Recruiting
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Nov 2015
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in chronic granulomatous disease (CGD), sponsored by IRCCS Ospedale San Raffaele. Started Nov 2015; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on NCT03055247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055247.